Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 11, 2016
[Immunodeficiency-associated Burkitt lymphoma developed in a patient receiving a long-term methotrexate therapy for rheumatoid arthritis]Takefumi Katsuragi, Atsushi Iwashige, Junichi TsukadaAnticancer Research|May 1, 2007
Evaluation of the quality of life between inpatients and outpatients receiving cancer chemotherapy in JapanHidetaka Uramoto, Seiji Kagami, Atsushi Iwashige, et al.Journal of UOEH|March 18, 2006
[Chemotherapy for lung cancer patients]Hidetaka Uramoto, Seiji Kagami, Atsushi Iwashige, et al.Journal of UOEH|June 20, 2006
[A medical economic benefit of outpatient with cancer chemotherapy]Hidetaka Uramoto, Atsushi Iwashige, Seiji Kagami, et al.Anticancer Research|May 1, 2007
Prediction of emergency hospitalization of outpatients receiving cancer chemotherapyHidetaka Uramoto, Atsushi Iwashige, Seiji Kagami, et al.Journal of UOEH|September 20, 2006
[Hormone therapy for breast cancer]Hidetaka Uramoto, Seiji Kagami, Atsushi Iwashige, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 17, 2006
[What do cancer chemotherapy outpatients want?--results of a questionnaire survey]Hidetaka Uramoto, Misako Kabashima, Kayoko Yamazaki, et al.American Journal of Hematology|June 30, 2004
Imatinib mesylate-sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: report of two casesTakehiro Higashi, Junichi Tsukada, Chiaki Kato, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 15, 2007
[Risk assessment for outpatients for cancer chemotherapy]Hidetaka Uramoto, Takaharu Ichiki, Yoshinori Shinohara, et al.Journal of UOEH|December 20, 2005
[Out-patient treatment for cancer patients at cancer chemotherapy centers in university hospitals]Hidetaka Uramoto, Atsushi Iwashige, Seiji Kagami, et al.Pageof 2